Orient Pharma Co., Ltd. (TPEX:4166)
Taiwan · Delayed Price · Currency is TWD 22.50
-0.05 (-0.22%)
Nov 10, 2026, 1:30 PM CST
Orient Pharma Market Cap
Orient Pharma has a market cap or net worth of 5.47 billion as of November 9, 2026. It is the 21,627th most valuable company in the world and the 1,000th biggest in Taiwan. Its market cap has decreased by 0.13% in one year.
Market Cap
5.47B
Enterprise Value
5.07B
Revenue
1.52B
Global Rank
Country Rank
#1,000 Taiwan
PE Ratio
23.00
ChartMarket Cap Chart
Since June 15, 2012, Orient Pharma's market cap has increased from 4.12B to 5.47B, an increase of 32.85%. That is a compound annual growth rate of 1.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 5.47B | -6.24% |
| Dec 31, 2025 | 5.83B | -27.36% |
| Dec 31, 2024 | 8.03B | 80.00% |
| Dec 29, 2023 | 4.46B | 14.13% |
| Dec 30, 2022 | 3.91B | 11.76% |
| Dec 30, 2021 | 3.50B | 28.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Standard Chemical & Pharmaceutical | 9.88B |
| SCI Pharmtech | 5.92B |
| Formosa Laboratories | 5.26B |
| Alar Pharmaceuticals | 4.93B |
| Yoda Pharmaceuticals | 4.84B |
| LIWANLI Innovation | 4.35B |
| Panion & Bf Biotech | 4.20B |
| Orient EuroPharma | 3.67B |